{"nct_id":"NCT01274351","title":"Study of Nilotinib as First Line Treatment in Philadelphia Chromosome Positive(Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)","status":"COMPLETED","status_verified_date":"2020-08","start_date":"2011-01-25","start_date_type":"ACTUAL","primary_completion_date":"2019-08-01","primary_completion_date_type":"ACTUAL","completion_date":"2019-08-01","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}